시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 신생아 POC 검사 시장 보고서(2025년)
Neonatal Point Of Care Testing Global Market Report 2025
상품코드 : 1855931
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,666,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,635,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,605,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

신생아 POC 검사 시장 규모는 최근 급속도로 확대되고 있습니다. 2024년 11억 6,000만 달러에서 2025년에는 13억 2,000만 달러에 달하고, CAGR 14.6%로 확대될 전망입니다. 실적기간 내 성장은 신생아 질환의 발생률 증가, 신속한 진단 결과에 대한 수요 증가, 신생아 건강 위험에 대한 인식 증가, 조산 유병률 증가, 병상 검사의 병원 도입 증가로 발생하였습니다.

신생아 POC 검사 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 14.4%로 22억 7,000만 달러로 성장할 전망입니다. 예측기간 내 성장은 개인화된 신생아 관리에 대한 수요 증가, 휴대용 검사 장비 채택 확대, 질병 조기 발견에 대한 선호도 증가, 신생아 사망률 감소에 대한 관심 증가, 고급 진단 도구에 대한 투자 확대에 의해 지원될 것으로 예측됩니다. 예측 기간 동안 예상되는 주요 동향으로는 바이오센서 기술 개발, 마이크로플루이딕스 기반 진단 플랫폼 혁신, 멀티플렉스 분석의 연구 개발 증가, 무선 신생아 모니터링 시스템 개발, 포인트 오브 케어 분자 검사 혁신 등이 있습니다.

원격 환자 모니터링의 수요 증가가 신생아 POC 검사 시장의 확대를 지원할 것으로 예측됩니다. 원격 환자 모니터링은 디지털 기술을 이용하여 환자를 직접 방문하지 않고 의료 전문가와 연결하고 건강 관리 서비스를 제공하는 것입니다. 이 수요는 특히 의료 인프라가 제한되어 있는 격오지나 의료 서비스가 제공되지 않는 지역에서 적시에 접근하기 쉬운 의료가 요구되면서 높아지고 있습니다. 신생아 POC 검사는 병상에서 진단 결과를 즉시 제공함으로써 건강 관리 제공업체가 중앙 검사실에 의존하지 않고 신생아의 중요한 건강 상태를 신속하게 확인하고 해결할 수 있도록 하여 원격 모니터링에 중요한 역할을 합니다. 예를 들어 미국에 본사를 두고 있는 의료기술기업 록헬스가 2023년 2월에 실시한 조사에 따르면 55세 이상 응답자의 76%가 원격의료를 이용한 적이 있고, 모든 참가자의 80%가 한 번 이상 원격의료를 이용하여 진료를 받았으며, 이는 2021년의 72%에서 증가한 수치입니다. 따라서 원격 환자 모니터링에 대한 수요 증가가 신생아 POC 검사 시장의 성장을 이끌고 있습니다.

신생아 POC 검사 시장의 주요 기업은 진단에 대한 접근을 확대하고 신생아의 조기 건강을 개선하기 위해 전략적 제휴를 맺고 있습니다. 전략적 협업이란 공동 목적을 달성하기 위해서 각각의 자원이나 전문지식을 결집하는 조직 간의 파트너십을 의미합니다. 예를 들어, 2025년 1월, 네덜란드에 본사를 두는 샘플 및 분석 기술 제공업체인 QIAGEN은 영국의 유전체 의료 조직인 Genomics England와 파트너십을 맺었습니다. 이 제휴는 영국에서 100,000명의 신생아의 유전체 서열을 결정하고 200개가 넘는 치료가능한 유 질환을 확인하기 위한 프로젝트 Generation Study의 출시를 위해 체결되었습니다. QIAGEN은 POC 시퀀싱으로 평가되는 유전자의 임상 관련 유전자 변이 데이터를 제공하여 보다 신속한 분석 및 결과 보고를 가능하게 합니다. 이 연구는 2024년 10월에 공식적으로 시작되었으며 영국에서 매년 약 3,000명의 신생아에 영향을 미치는 질병의 조기 발견과 치료에 영향을 미칠 것으로 기대됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

CSM
영문 목차

영문목차

Neonatal point-of-care testing is the practice of performing diagnostic evaluations near the location where newborns receive care. It provides immediate clinical information, enabling rapid and informed decision-making. This approach delivers timely and accurate results while reducing the delays and logistical challenges associated with traditional laboratory testing.

The primary products in neonatal point-of-care testing include instruments and assays. Instruments consist of portable analyzers, handheld readers, and bedside monitors used to assess newborn health directly in care settings. Test types include neonatal bilirubin testing, newborn metabolic screening, blood glucose testing, infectious disease screening, electrolyte testing, and others. Key end-users include hospitals, diagnostic centers, maternity and specialty clinics, and additional healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The neonatal point of care testing market research report is one of a series of new reports from The Business Research Company that provides neonatal point of care testing market statistics, including neonatal point of care testing industry global market size, regional shares, competitors with a neonatal point of care testing market share, detailed neonatal point of care testing market segments, market trends and opportunities, and any further data you may need to thrive in the neonatal point of care testing industry. This neonatal point of care testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neonatal point of care testing market size has grown rapidly in recent years. It will grow from $1.16 billion in 2024 to $1.32 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. Growth in the historic period was driven by the rising incidence of neonatal disorders, increasing demand for rapid diagnostic results, greater awareness of neonatal health risks, higher prevalence of preterm births, and growing hospital adoption of bedside testing.

The neonatal point of care testing market size is expected to see rapid growth in the next few years. It will grow to $2.27 billion in 2029 at a compound annual growth rate (CAGR) of 14.4%. Growth in the forecast period is expected to be supported by rising demand for personalized neonatal care, increased adoption of portable testing devices, growing preference for early disease detection, heightened focus on reducing neonatal mortality rates, and greater investment in advanced diagnostic tools. Key trends anticipated for the forecast period include advancements in biosensor technology, innovation in microfluidic-based diagnostic platforms, increased research and development for multiplex assays, development of wireless neonatal monitoring systems, and innovation in point-of-care molecular testing.

The growing demand for remote patient monitoring is anticipated to support the expansion of the neonatal point of care testing market. Remote patient monitoring refers to the use of digital technology to provide healthcare services by connecting patients with medical professionals without requiring in-person visits. This demand is rising due to the need for timely, accessible care, particularly in remote and underserved areas where medical infrastructure may be limited. Neonatal point of care testing plays a key role in remote monitoring by delivering immediate diagnostic results at the bedside, allowing healthcare providers to rapidly identify and address critical health conditions in newborns without depending on central laboratories. For example, in February 2023, a survey conducted by Rock Health, a health technology company based in the United States, showed that seventy-six percent of respondents over the age of fifty-five had used telemedicine, while eighty percent of all participants had accessed healthcare through telemedicine at some point in their lives, up from seventy-two percent in 2021. Therefore, the rising demand for remote patient monitoring is driving growth in the neonatal point of care testing market.

Leading companies in the neonatal point of care testing market are forming strategic collaborations to expand access to diagnostics and improve early healthcare for newborns. Strategic collaborations involve partnerships between organizations that combine their resources and expertise to reach shared objectives. For example, in January 2025, QIAGEN, a provider of sample and assay technologies based in the Netherlands, entered a partnership with Genomics England, a genomic medicine organization located in the United Kingdom. This collaboration supported the launch of the Generation Study, a project aimed at sequencing the genomes of one hundred thousand newborns in England to identify more than two hundred treatable genetic conditions. QIAGEN is contributing clinically relevant genetic variant data for the genes assessed in the point of care sequencing test, enabling faster analysis and reporting of results. The study officially began in October 2024 and is expected to impact the early detection and treatment of conditions affecting approximately three thousand newborns each year in the United Kingdom.

In March 2025, LaCAR MDx Technologies, a biotechnology company based in Belgium, acquired the newborn screening division of Baebies Incorporated for an undisclosed amount. This acquisition expands LaCAR's portfolio by increasing the range of neonatal diagnostic solutions it can offer and supports the company's growth in the United States market. Baebies Incorporated is a company based in the United States that specializes in neonatal point of care testing.

Major players in the neonatal point of care testing market are Abbott Laboratories, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Konica Minolta Inc., Drager Ag Co. Kg, Bio-Rad Laboratories Inc., Masimo Corporation, QIAGEN Inc., Radiometer Ltd., Contec Medical Systems Co. Ltd., Owen Mumford Ltd., Nova Biomedical, Heal Force Bio Meditech Holdings Ltd., Edan Instruments Inc., Trivitron Healthcare, Bistos Co. Ltd., Bilimetrix S.r.I, GINEVRI srl, Hadleigh Health Technologies.

North America was the largest region in the neonatal point of care testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neonatal point of care testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neonatal point of care testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neonatal point of care testing market consists of revenues earned by entities by providing services such as rapid diagnostic screening, blood gas and electrolyte analysis, glucose level monitoring, and sepsis detection. The market value includes the value of related goods sold by the service provider or included within the service offering. The neonatal point of care testing market also includes sales of portable diagnostic analyzers, oxygen saturation monitors, hematology analyzers, and lactate analyzers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neonatal Point Of Care Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neonatal point of care testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for neonatal point of care testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neonatal point of care testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Neonatal Point Of Care Testing Market Characteristics

3. Neonatal Point Of Care Testing Market Trends And Strategies

4. Neonatal Point Of Care Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Neonatal Point Of Care Testing Growth Analysis And Strategic Analysis Framework

6. Neonatal Point Of Care Testing Market Segmentation

7. Neonatal Point Of Care Testing Market Regional And Country Analysis

8. Asia-Pacific Neonatal Point Of Care Testing Market

9. China Neonatal Point Of Care Testing Market

10. India Neonatal Point Of Care Testing Market

11. Japan Neonatal Point Of Care Testing Market

12. Australia Neonatal Point Of Care Testing Market

13. Indonesia Neonatal Point Of Care Testing Market

14. South Korea Neonatal Point Of Care Testing Market

15. Western Europe Neonatal Point Of Care Testing Market

16. UK Neonatal Point Of Care Testing Market

17. Germany Neonatal Point Of Care Testing Market

18. France Neonatal Point Of Care Testing Market

19. Italy Neonatal Point Of Care Testing Market

20. Spain Neonatal Point Of Care Testing Market

21. Eastern Europe Neonatal Point Of Care Testing Market

22. Russia Neonatal Point Of Care Testing Market

23. North America Neonatal Point Of Care Testing Market

24. USA Neonatal Point Of Care Testing Market

25. Canada Neonatal Point Of Care Testing Market

26. South America Neonatal Point Of Care Testing Market

27. Brazil Neonatal Point Of Care Testing Market

28. Middle East Neonatal Point Of Care Testing Market

29. Africa Neonatal Point Of Care Testing Market

30. Neonatal Point Of Care Testing Market Competitive Landscape And Company Profiles

31. Neonatal Point Of Care Testing Market Other Major And Innovative Companies

32. Global Neonatal Point Of Care Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neonatal Point Of Care Testing Market

34. Recent Developments In The Neonatal Point Of Care Testing Market

35. Neonatal Point Of Care Testing Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기